These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1586148)

  • 1. Brain 31P-magnetic resonance spectroscopy in mitochondrial cytopathies.
    Montagna P; Martinelli P; Cortelli P; Zaniol P; Lugaresi E; Barbiroli B
    Ann Neurol; 1992 Apr; 31(4):451-2. PubMed ID: 1586148
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies.
    Matthews PM; Arnold DL
    Ann Neurol; 1990 Dec; 28(6):839-40. PubMed ID: 2285271
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine.
    Eleff SM; Barker PB; Blackband SJ; Chatham JC; Lutz NW; Johns DR; Bryan RN
    Ann Neurol; 1990 Jun; 27(6):626-30. PubMed ID: 2360799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance imaging and spectroscopy of the brain: a new approach of cerebral physiopathology].
    Cozzone PJ; Vion-Dury J; Confort-Gouny S
    Ann Fr Anesth Reanim; 1992; 11(6):666-71. PubMed ID: 1300065
    [No Abstract]   [Full Text] [Related]  

  • 5. A mitochondrial encephalomyopathy. A combined 31P magnetic resonance and biochemical investigation.
    Hayes DJ; Hilton-Jones D; Arnold DL; Galloway G; Styles P; Duncan J; Radda GK
    J Neurol Sci; 1985 Nov; 71(1):105-18. PubMed ID: 4087016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies.
    Barbiroli B; Montagna P; Martinelli P; Lodi R; Iotti S; Cortelli P; Funicello R; Zaniol P
    J Cereb Blood Flow Metab; 1993 May; 13(3):469-74. PubMed ID: 8478405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy.
    Barbiroli B; Frassineti C; Martinelli P; Iotti S; Lodi R; Cortelli P; Montagna P
    Cell Mol Biol (Noisy-le-grand); 1997 Jul; 43(5):741-9. PubMed ID: 9298596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains.
    Hugg JW; Matson GB; Twieg DB; Maudsley AA; Sappey-Marinier D; Weiner MW
    Magn Reson Imaging; 1992; 10(2):227-43. PubMed ID: 1564992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced MR brain imaging. Why?
    Huisman TA; Tekes A
    Pediatr Radiol; 2008 Jun; 38 Suppl 3():S415-32. PubMed ID: 18470451
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study.
    Nishikawa Y; Takahashi M; Yorifuji S; Nakamura Y; Ueno S; Tarui S; Kozuka T; Nishimura T
    Neurology; 1989 Mar; 39(3):399-403. PubMed ID: 2538775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Magnetic resonance--more than just images! New MR techniques improve diagnosis, therapeutic control and assessment of brain function].
    Holtäs S; Ståhlberg F
    Lakartidningen; 1998 Jan; 95(4):266-70. PubMed ID: 9469959
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of magnetic resonance spectroscopy of the brain (review of the literature)].
    Kossovoĭ AL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):113-7. PubMed ID: 1665638
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnetic resonance in childhood white-matter disorders.
    van der Knaap MS
    Dev Med Child Neurol; 2001 Oct; 43(10):705-12. PubMed ID: 11665829
    [No Abstract]   [Full Text] [Related]  

  • 14. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?
    Vion-Dury J; Meyerhoff DJ; Cozzone PJ; Weiner MW
    J Neurol; 1994 May; 241(6):354-71. PubMed ID: 7931430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of 31P magnetic resonance spectroscopy to characterize evolving brain damage after perinatal asphyxia.
    Laptook AR; Corbett RJ; Uauy R; Mize C; Mendelsohn D; Nunnally RL
    Neurology; 1989 May; 39(5):709-12. PubMed ID: 2710361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF).
    Matthews PM; Berkovic SF; Shoubridge EA; Andermann F; Karpati G; Carpenter S; Arnold DL
    Ann Neurol; 1991 Apr; 29(4):435-8. PubMed ID: 1929212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of the infant brain.
    Ball WS
    Semin Ultrasound CT MR; 1991 Oct; 12(5):379-409. PubMed ID: 1742053
    [No Abstract]   [Full Text] [Related]  

  • 18. Image-guided localized 1H and 31P NMR spectroscopy of humans.
    den Hollander JA; Luyten PR
    Ann N Y Acad Sci; 1987; 508():386-98. PubMed ID: 3439711
    [No Abstract]   [Full Text] [Related]  

  • 19. 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders.
    van der Knaap MS; van der Grond J; Luyten PR; den Hollander JA; Nauta JJ; Valk J
    Ann Neurol; 1992 Feb; 31(2):202-11. PubMed ID: 1575459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.
    Hinsberger AD; Williamson PC; Carr TJ; Stanley JA; Drost DJ; Densmore M; MacFabe GC; Montemurro DG
    J Psychiatry Neurosci; 1997 Mar; 22(2):111-7. PubMed ID: 9074305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.